Dr. Adam S. Alli, MD

Dr. Alli practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Alli's NPI, 1215153531, was assigned on April 17, 2007. Dr. Alli graduated from OU College of Medicine in 2006. Dr. Alli's Texas license number on file is P7877.

Dr. Alli's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Alli's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Alli is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Alli to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alli practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Alli's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Alli is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Alli's licenses on file in 3 states: Texas, Kansas and Missouri.

CMS data shows 837 Medicare services from Dr. Alli across 26 procedure codes in 2024, for 506 Medicare patients. Medicare paid $67,506 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 506 Medicare patients who saw Dr. Alli in 2024. The largest group is 65 to 74, with 250 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alli's median patient age at 70, with 51% women.

In 2024, Dr. Alli wrote 122 Medicare Part D claims for 62 patients. 98% of them were for generic drugs. CMS names the drug for 106 of them, across 5 drugs with 11 or more claims each, at $814 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Alli for performance year 2024, reported through an alternative payment model (APM). Dr. Alli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alli as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Alli, published from 2013 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Amputation, Surgical, Arteriovenous Malformations and Peripheral Arterial Disease. Dr. Alli has published most often in Am J Case Rep. Dr. Alli's most frequent co-authors are Kamal Gupta, MD, Zachary Seth Collins, MD and Philip L. Johnson, MD.

Dmand AI links Dr. Alli to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pelvic Pain and Pain.

CMS Open Payments shows 451 general payments to Dr. Alli from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Sirtex Medical Inc paid the most, $124,195.

Dmand AI lists 3 awards for Dr. Alli, most recently Peter Ronai First Year Radiology Resident Award in 2010.

Dr. Alli graduated from OU College of Medicine in 2006. Dr. Alli is a member of SIR.

Dr. Alli is in network with 21 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.